Issue 20, 2025, Issue in Progress

Hyaluronic acid-loaded drug-eluting nanofibrous pad for the treatment of degenerative arthritis

Abstract

Despite advancements in modern technology, treating degenerative arthritis remains a challenge. This study developed a degradable, hyaluronic acid-loaded, drug-eluting nanofibrous pad designed to provide extended pain relief and prevent infection at the knee joint. The mechanical performance of the biodegradable pads was assessed, and the pharmaceutical discharge kinetics were estimated using an in vitro elution method. Additionally, in vivo pharmaceutical release and efficacy were tested using a rabbit activity model. The experimental results suggest that the degradable pad exhibited strong mechanical properties. In vitro, the drug-eluting nanofibrous pad sustained the release of teicoplanin, ceftazidime, and ketorolac for 10, 24, and 30 days, respectively, and maintained high levels of connective tissue growth factor elution over a 30-day period. Moreover, animal testing demonstrated that the pad released significant amounts of antimicrobial and pain-relieving agents in a rabbit knee joint model for over 28 days. Rabbits implanted with the drug-eluting pads exhibited activity levels comparable to those that did not undergo surgery. These findings indicate that the hyaluronic acid-loaded, drug-eluting nanofibrous degradable pad, with its extended release of pharmaceuticals and biomolecules, may be used for the treatment of degenerative arthritis.

Graphical abstract: Hyaluronic acid-loaded drug-eluting nanofibrous pad for the treatment of degenerative arthritis

Article information

Article type
Paper
Submitted
03 Mar 2025
Accepted
02 May 2025
First published
12 May 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 15505-15515

Hyaluronic acid-loaded drug-eluting nanofibrous pad for the treatment of degenerative arthritis

Y. Hsu, P. Feng, Y. Yu, Y. Chou, Z. Wang and S. Liu, RSC Adv., 2025, 15, 15505 DOI: 10.1039/D5RA01494H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements